GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Harbin Pharmaceutical Group Co Ltd (SHSE:600664) » Definitions » 5-Year Yield-on-Cost %

Harbin Pharmaceutical Group Co (SHSE:600664) 5-Year Yield-on-Cost % : 0.00 (As of Jun. 13, 2024)


View and export this data going back to 1993. Start your Free Trial

What is Harbin Pharmaceutical Group Co 5-Year Yield-on-Cost %?

Harbin Pharmaceutical Group Co's yield on cost for the quarter that ended in Mar. 2024 was 0.00.


The historical rank and industry rank for Harbin Pharmaceutical Group Co's 5-Year Yield-on-Cost % or its related term are showing as below:


During the past 13 years, Harbin Pharmaceutical Group Co's highest Yield on Cost was 14.58. The lowest was 0.00. And the median was 8.82.


SHSE:600664's 5-Year Yield-on-Cost % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.23
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Harbin Pharmaceutical Group Co's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, Harbin Pharmaceutical Group Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Harbin Pharmaceutical Group Co's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Harbin Pharmaceutical Group Co's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Harbin Pharmaceutical Group Co's 5-Year Yield-on-Cost % falls into.



Harbin Pharmaceutical Group Co 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Harbin Pharmaceutical Group Co is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Harbin Pharmaceutical Group Co  (SHSE:600664) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Harbin Pharmaceutical Group Co 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Harbin Pharmaceutical Group Co's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Harbin Pharmaceutical Group Co (SHSE:600664) Business Description

Traded in Other Exchanges
N/A
Address
Xi'an Street West, People 's Development Zone Baoan Road South, Heilongjiang Province, Harbin, CHN, 150018
Harbin Pharmaceutical Group Co Ltd is engaged in manufacturing, trading and research and development of pharmaceuticals. The company is organized into seven business segments - Antibiotics, Small-Molecular drug preparations, OTC and healthcare products, Modern Chinese medicines, Biopharmaceuticals, Animal vaccines, and medicine circulations. The company sells its products across China and fifty other countries. Some of its brands are - Hayao, Sanjing, Gaizhonggai, Hutong, and Shiyitang.
Executives
Lin Guo Ren senior management
Wang Hai Sheng senior management
Liu Bo senior management
Meng Xiao Dong senior management
Xu Hai Ying Directors, senior managers
Liang Chen senior management
Wang Peng Hao senior management
Xiao Qiang senior management
Wei Shuang Ying senior management
Zhou Xing senior management
Bian Ke Supervisors
Sha Mei senior management
Jian Shi Hui Zhu Xi Supervisors
Wang Zhi Fu Supervisors
Jiang Lu Director

Harbin Pharmaceutical Group Co (SHSE:600664) Headlines

No Headlines